Culwell Kelly 4
4 · Evofem Biosciences, Inc. · Filed Dec 4, 2019
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-12-02$7.35/sh−1,000$7,350→ 43,538 total
Footnotes (1)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.